// App-Quantinova.ai

2029 : Heterogeneity of HER2 expression in circulating tumor cells of patients with breast cancer brain metastases and impact on brain disease control.

Researchers

Presenter

  • Douglas Guedes Castro

Principal Investigators

  • Antonio Cassio Assis Pellizzon

  • Alexcia Camila Braun

  • Michael Jenwei Chen

  • Maria Leticia Gobo Silva

  • Ricardo Fogaroli

  • Guilherme Rocha Melo Gondim

  • Henderson Ramos

  • Elson Santos Neto

  • Carolina Humeres Abrahao

  • Liao Shin Yu

  • Emne Ali Abdallah

  • Vinicius Fernando Calsavara

  • Ludmilla T.D. Chinen

Medical Centers

  • A.C. Camargo Cancer Center, Sao Paulo, Brazil

Locations

  • Brazil

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Brain metastasis

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Circulating tumor cells

  • erb-b2 receptor tyrosine kinase 2

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Prospective

Phase

  • N/A

Study Id's

  • NCT02941536

Sponsors

  • N/A

Result

  • N/A